National Lipid Association Annual Summary of Clinical Lipidology 2016 Disclosures

Dr. Harold E. Bays: Dr. Bays discloses that he has received research grants from Arena Pharmaceuticals, Boehringer Ingelheim, Cargill Inc., GlaxoSmithKline, Novo Nordisk, Orexigen Therapeutics, Shionogi, Takeda, Stratum Nutrition, California Raisin Board, Esperion, Essentialis, Forest, Gilead Sciences Inc., Given, Hoffman-LaRoche, Home Access, Novartis, Omthera, Pfizer, Trygg Pharmaceuticals, TWI Bio, Xoma, Ardea Inc., High Point Pharmaceuticals LLC, Micropharma Limited, TransTech Pharma Inc., TIMI, Pozen, Regeneron, and Elcelyx. He further discloses that he has received honoraria/research grants from Amarin, Amgen, AstraZeneca, Bristol-Myers Squibb, Catabasis, Daiichi-Sankyo Inc., Eisai, Merck & Co, VIVUS, Zeomedex, and WPU.

Dr. Peter H. Jones: Dr. Jones has received consulting or speaker honoraria from Merck and Co., Amgen, and Sanofi-Aventis/Regeneron.

Dr. W. Virgil Brown: Dr. Brown is the editor of the Journal of Clinical Lipidology and further discloses that he has received consulting fees/honoraria from Akcea, Esperion, Regeneron, Amgen, Genzyme, Pfizer Inc., Merck and Co, GlaxoSmithKline, Medtelligence, and Vindico.

Dr. Terry A. Jacobson: Dr. Jacobson has received consulting fees from Merck and Co., Amarin, Amgen, AstraZeneca, and Regeneron/Sanofi-Aventis.

Dr. Karen E. Aspry: Dr. Aspry has no disclosures to report.

Dr. Christie M. Ballantyne: Dr. Ballantyne has received research grants from Abbott Diagnostics, Amarin, Amgen, Eli Lilly, Esperion, ISIS Pharmaceuticals, Novartis Pharmaceuticals, Pfizer, Otsuka, Regeneron, Roche Diagnostic, Sanofi-Synthelabo, and Takeda Pharmaceuticals. He has also received consulting fees from Abbott Diagnostics, Amarin, Amgen, AstraZeneca, Eli Lilly, Esperion, Genzyme, ISIS Pharmaceuticals, Matinas BioPharma Inc., Merck and Co., Novartis Pharmaceuticals, Pfizer, Regeneron, Roche, and Sanofi-Synthelabo.

Dr. Keith C. Ferdinand: Dr. Ferdinand discloses that he has received consulting honoraria from Amgen, Sanofi, and Lilly, and further discloses that he received contracted research from Boehringer Ingelheim.

Dr. Anne C. Goldberg: Dr. Goldberg discloses that she received research grants as a principle investigator from Amarin, Pfizer, Merck & Co., Genzyme/ISIS, Regeneron/Sanofi-Aventis, Amgen, Arisaph, and ISIS. Dr. Goldberg also discloses that she received consultant honorarium from Sanofi/Regeneron and OptumRX, and honorarium from Merck.

Dr. John R. Guyton: Dr. Guyton has received consulting fees from Amgen, UpToDate, and Regeneron/Sanofi. He has received research grants from Genzyme/Sanofi, Amgen, Amarin Pharma, Regeneron/Sanofi, and the FH Foundation. He has also received honorarium from St. Dominic Hospital.

Dr. Penny Kris-Etherton: Dr. Kris-Etherton has received advisory board honoraria from Solazyme, Avocado Nutrition Sciences Advisors, Seafood Nutrition Partnership, and McDonald’s Global Advisory Council. She further discloses that she has received research grants from Hershey Foods and Almond Board of CA, Solae/DuPont, California Strawberry Commission, California Walnut Commission, Ag Canada and Canola Oil Council, Ocean Spray Cranberries, and National Cattlemen’s Beef Association.

Mr. Ralph LaForge: Ralph LaForge has nothing to disclose.

Dr. James M. McKenney: Dr. McKenney has nothing to disclose.

Dr. Patrick M. Moriarty: Dr. Moriarty has received grant research support from Genzyme, Regeneron, Sanofi, Amgen, ISIS, Catabasis, Pfizer, Novartis, NIH, and Kaneka. Dr. Moriarty has received speaker fees from Genzyme, Regeneron, Sanofi, Amgen, and Aegerion. He has received consulting fees from Duke and Cymabay Therapeutics, and advisor fees from ISIS and Aegerion. Dr. Moriarty has also received an educator fee from Synageva.

Dr. Pamela B. Morris: Dr. Morris discloses that she has received advisory board honoraria from Amgen, AstraZeneca, and Sanofi/Regeneron.

Dr. Carl E. Orringer: Dr. Orringer has nothing to disclose.

Dr. Robert S. Rosenson: Dr. Rosenson has received consulting fees from Sanofi-Aventis, Regeneron, Amgen, AstraZeneca, and Eli Lilly & Co. He has also received author royalty from UpToDate Inc. and speaker honoraria from Kowa.

Ms. Joyce L. Ross: Joyce Ross received speaker honoraria from AbbVie, AstraZeneca, Amarin, Amgen, and Sanofi/Regeneron.

Dr. Joseph J. Saseen: Dr. Saseen has no disclosures to report.

Dr. James A. Underberg: Dr. Underberg has received consulting fees or honoraria from Eli Lilly & Co., GLG Group, Genzyme, Akcea, Recombine, Guidepoint Global, Amarin, Aegerion, Amgen, Sanofi, AstraZeneca, and Synageva/Alexion. He has received advisory board and/or speakers bureau honoraria from Regeneron, Merck & Co. Genzyme, Amgen, Sanofi, and Synageva/Alexion. He has received research support from Genzyme, Pfizer, and Aegerion.

Dr. Robert A. Wild: Dr. Wild discloses that he has received consulting honoraria from the National Institutes of Health and the Food and Drug Administration.

Dr. Kaye-Eileen Willard: Dr. Willard has no disclosures to report.

Dr. Don P. Wilson: Dr. Wilson discloses that he has received speaker honoraria from Osler Institute, Alexion Pharmaceuticals, and Insulet Corp. and further discloses that he participated on the advisory board for Aegerion Pharmaceuticals and Alexion Pharmaceuticals. He also discloses that he has received research funding from Merck Sharpe & Dohme and Novo Nordisk Inc.

Dr. Alan Brown: Dr. Brown has received speaker honorarium from Amarin, Amgen, Merck, and Regeneron/Sanofi. He has received advisory board honorarium from AKCEA, Amarin, Amgen, AstraZeneca, Kowa, Lilly, Merck, and Regeneron/Sanofi.

Dr. Dean Bramlet: Dr. Bramlet has received speaker or consultant honoraria from Merck, Kowa, Amarin, Sanofi, AstraZeneca, and Aegerion.

Dr. Eliot Brinton: Dr. Brinton has received research funding from Amarin, Aurora Foundation, Health Diagnostic Laboratory, and the NIH. He has received honoraria as a consultant/advisor from Aegerion, Amarin, Amgen, Aralez, Arisaph, AstraZeneca, Essentialis, Genzyme, Kowa, Merck, PTS Diagnostics, Regeneron, and Sanorfi-Aventis. He also received speaker honoraria from Alexion, Amarin, Amgen, AstraZeneca, Genzyme, Jannssen, Kowa, Merck, Regeneron, Sanofi-Aventis, and Takeda.

Dr. Sergio Fazio: Dr. Fazio has received consultant and advisory board honoraria from Merck, Kowa, Sanofi, NHP, and Aegerion.

Geeta Sikand: Geeta Sikand has nothing disclose.

Dr. Robert Eckel: Dr. Eckel has received consultant honorarium from Amarin, Amylin Pharmaceuticals, Eli Lilly & Co., Genentech, Johnson & Johnson, and Novo Nordisk. He has received consulting fees from Regeneron and Sanofi-Aventis and a research grant from Esperion. He also received speaker honorarium from Vindico Medical Education, Intellyst, and Cardiometabolic Health Congress.

Dr. Kevin Maki: Dr. Maki has received consulting fees and research grants from AbbVie, Matinas BioPharma, AstraZeneca, Pharmavite, Sancilio & Co., DuPont, ACH Foods, Shaklee, Egg Nutrition Center, National Dairy Council, and National Cattlemen’s Beef Association.

Dr. Eric Westman: Dr. Westman discloses that he has ownership interest in Low Carb Adapt and HEAL Clinics.

Dr. Kenneth Kellick: Dr. Kellick has no disclosures to report.

Dr. Bart Duell: Dr. Duell has received research grants and/or honoraria from Genzyme, Sanofi, Regeneron, Retrophin, Lilly, Amgen, and Kaneka.

Dr. Linda Hemphill: Dr. Hemphill has nothing to disclose.

Dr. Stephen Daniels: Dr. Daniels has nothing to disclose.

Dr. Krishnaswami Vijayaraghavan: Dr. Vijayaraghavan discloses that he received consultant/speaker honoraria from Aegerion, AstraZeneca, Amarin, Amgen, Otsuka, Novartis, and Sanofi. He further discloses that he has received advisory board honoraria from ZS Pharma and Amarin, and received a research grant from Otsuka.

Dr. Prakash Deedwania: Dr. Deedwania has received consultant/speaker honoraria from Amgen, Sanofi/Regeneron, Pfizer, and Merck.

Dr. Judith Aberg: Dr. Aberg received a fee from involvement on the scientific advisory board for Janssen, Merck, and Viiv.

Dr. Kat Liao: Dr. Liao has nothing to disclose.

Dr. Lynne Braun: Dr. Braun received speaker honoraria from Practice Point and author/NP advisory board honoraria from UpToDate.